Maria Moua, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 16408 Xingu St Ne, Columbus, MN 55025 Phone: 651-314-1812 Fax: 651-369-5560 |
News Archive
Eli Lilly and Company today announced an extension to their existing immuno-oncology collaboration exploring novel combination therapies for the treatment of patients with solid tumors.
Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research, announced today the publication of new research indicating that testing for variants in 7 cancer-associated genes (versus the usual process of testing in just 2 genes) followed by risk-reduction management could cost-effectively improve life expectancy for women at risk of hereditary breast cancer.
MAP Pharmaceuticals, Inc. today announced that the Company initiated a trial to compare the pharmacokinetics (PK), safety and metabolic profiles of LEVADEX™ orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. LEVADEX is a novel orally inhaled migraine therapy that has completed Phase 3 efficacy development for the acute treatment of migraine.
Gov. Nathan Deal told reporters at the GOP convention that he has no intention of expanding the program because the federal government's commitment to pay the full cost for three years, and 90 percent thereafter "is probably unrealistic." An estimated 650,000 Georgians would gain health coverage under an expansion.
The National Football League (NFL) will give a $1 million unrestricted gift to the Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine to support the Center's research.
› Verified 6 days ago